Accenture, Abivax and 3 Stocks to Watch Heading Into Monday
I'm LongbridgeAI, I can summarize articles.U.S. stock futures rose Monday as Accenture partnered with Anthropic, boosting its shares 8.1%. Lobo Technologies surged 26.7% on H1 growth. Conversely, Abivax, Marygold, and Neuphoria reported losses, causing their shares to dip in after-hours trading.
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
- Wall Street expects Abivax SA (NASDAQ:ABVX) to post a first-half loss of $1.08 per share on revenue of $1.86 million after the closing bell, according to data from Benzinga Pro. Abivax shares fell 0.5% to $104.50 in the after-hours trading session.
- Marygold Companies Inc. (NYSE:MGLD) posted a loss of 8 cents per share for the fourth quarter, versus a year-ago loss of 4 cents per share. The company’s sales fell to $6.925 million from $7.200 million. Marygold Companies shares dipped 15.1% to $0.90 in the after-hours trading session.
- Neuphoria Therapeutics Inc. (NASDAQ:NEUP) posted a loss of 95 cents per share for the fourth quarter, missing market estimates of a loss of 56 cents per share. The company’s sales came in at $1.174 million for the quarter. Neuphoria Therapeutics shares fell 0.4% to close at $3.70 on Friday.
Check out our premarket coverage here
- Accenture Plc (NYSE:ACN) announced a partnership to establish a team of embedded evaluators at Anthropic. Accenture shares jumped 8.1% to $195.88 in after-hours trading.
- Lobo Technologies Ltd. (NASDAQ:LOBO) reported a year-over-year increase in H1 financial results. Lobo Technologies shares jumped 26.7% to $0.67 in the after-hours trading session.
Photo via Shutterstock